Marque Allen, DPM
Foot Surgery · San Antonio, TXNPI 1124175807
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $160,250 of the $203,920 with a category attached, or 78.6%. Treace Medical Concepts, Inc. accounts for 96.6% of it on its own, with 17 other manufacturers making up the rest. Among foot surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 442 payments — averaging $461.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$197K
- Stryker$2K
- Arthrex$696
- Mission Medical Distribution, LLC$691
- Medinc Of Texas$683
- Bioventus LLC$627
- plus $2K from 12 others
Across 44 payments — averaging $807.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Treace Medical Concepts, Inc.$36K
What the payments were for
- Consulting fees$160,25079%
- Travel & lodging$34,62217%
- Food & beverage$8,3774%
- Education$6700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 210 | $196,919 |
| Stryker | 19 | $1,957 |
| Arthrex | 7 | $696 |
| Mission Medical Distribution, LLC | 12 | $691 |
| Medinc Of Texas | 2 | $683 |
| Bioventus LLC | 51 | $627 |
| KCI USA, Inc. | 1 | $550 |
| Zyla Life Sciences, Inc. | 87 | $507 |
| Johnson & Johnson | 3 | $363 |
| Paragon 28, Inc. | 3 | $355 |
| Amgen | 30 | $277 |
| Voom Medical Devices, Inc. | 4 | $159 |
| Orthofix Medical, Inc. | 7 | $38 |
| Pacira Therapeutics, Inc. | 2 | $34 |
| Vertex | 1 | $27 |
| Assertio Therapeutics, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$131,425
- LAPIPLASTY SYSTEM 1$59,431
- Lapiplasty$974
- INFINITY$830
- PREVENA$550
- XARELTO$363
- APEX 3D$320
- TMC NANOPLASTY SYSTEM$300
- INFINITY ADAPTIS$241
- TMC SPEEDTMT$142
- EASY CLIP$101
- ALLOGRAFT$101
How this compares
$203,920 in reported general payments places this provider in the 95th percentile of 71 foot surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 14 | $7,661 |
| Gabapentin | 110 | $1,055 |
| Methylprednisolone | 130 | $889 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $564 |
| Meloxicam | 86 | $468 |
| Ibuprofen | 124 | $354 |
| Cephalexin | 62 | $248 |
| Ondansetron Hcl | 65 | $214 |
| Terbinafine Hcl | 13 | $85 |
| Tramadol Hcl | 13 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $363 | $7,66114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 71 foot surgery providers in Texas.
Other foot surgery in San Antonio
- Lawrence LaverySan Antonio$59K
- Richard KehSan Antonio$17K
- Seth AshrafSan Antonio$17K
- Kris FordSan Antonio$15K
- Joshua WardSan Antonio$5K
- Jonathan LorenzanaSan Antonio$4K
- Caroline GaynorSan Antonio$2K
- Jason MirelesSan Antonio$1K
- Marvin SanchezSan Antonio$614
- W Brent GillespieSan Antonio$383
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.